The patient support program Cycle Vita will be available for people with MS taking Bafiertam (monomethyl fumarate) starting in April.

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the ...

Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...

Optum Rx has eliminated reauthorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior authorizations. Optum Rx is eliminating reauthorization on almost 70 drugs for ...

The U.S. Food and Drug Administration approved Bafiertam (monomethyl fumarate), delayed-release capsules that target relapsing forms of MS. “The FDA’s final approval marks an important milestone for ...